Email: dvtustudies@duke.edu | Telephone: 919-971-5649
Active Clinical Trials
Dr. Walter is leading a study designed to obtain blood from Duke employees who are recovering from SARS-CoV-2 infection for the purposes of neutralizing antibody assay validation. No NCT number.
Dr. Smith is leading a study to assess the safety, tolerability, and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy infants. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06524414.
Dr. Walter is leading A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen (Bird Flu) mRNA-LNP Vaccine in Healthy Adults. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07019883.
Dr. Walter is leading A Study to Evaluate the Safety and Immunogenicity of Two Doses of a novel adjuvanted pancoronavirus vaccine in Healthy Adults. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT06950177.